Keytruda, known by its generic name pembrolizumab, represents a significant advancement in the field of oncology. Unlike traditional treatments that target cancer cells directly, Keytruda is a type of immunotherapy that works by helping your own immune system recognize and attack cancer cells. This guide provides a clear overview of how this medication works, the types of cancer it treats, and what patients should expect regarding side effects and administration.
What Is Keytruda?
Keytruda is a prescription medicine classified as an immune checkpoint inhibitor. It is designed to treat various types of advanced cancers that have either spread to other parts of the body or cannot be removed by surgery. Because it utilizes the body’s natural defenses, it is often referred to as a “biological therapy.”
The medication is administered as an intravenous (IV) infusion. It is not a pill or a chemotherapy drug, though it is sometimes used in combination with chemotherapy to improve patient outcomes. Understanding the distinction between immunotherapy and chemotherapy is essential for patients and caregivers as they navigate a treatment plan.
How Keytruda Works in the Body
To understand how Keytruda works, it helps to understand how the immune system normally functions. Your immune system uses “checkpoints” to prevent it from attacking healthy cells. Cancer cells often find ways to use these checkpoints to hide from the immune system.
The Role of PD-1
Many cancer cells produce a protein called PD-L1. When this protein binds to the PD-1 receptor on your immune cells (T-cells), it sends a signal to the T-cell to ignore the cancer. Keytruda works by blocking this interaction. By binding to the PD-1 receptor itself, the medication prevents cancer cells from “turning off” the immune response.
Unmasking Cancer Cells
Once the PD-1 pathway is blocked, your T-cells can better detect the cancer cells. This allows your immune system to do what it was designed to do: find and destroy harmful cells. This targeted approach is why Keytruda can be effective across many different types of cancer, regardless of where in the body the tumor originated.
Cancers Commonly Treated with Keytruda
The Federal Drug Administration (FDA) has approved Keytruda for a wide range of indications. Medical professionals may prescribe it for the following conditions:
- Melanoma: For skin cancer that has spread or cannot be removed by surgery.
- Non-Small Cell Lung Cancer (NSCLC): Often used as a first-line treatment or when other treatments have failed.
- Head and Neck Squamous Cell Carcinoma: For patients with recurrent or metastatic disease.
- Classical Hodgkin Lymphoma: For adults and children who have not responded to other treatments.
- Urothelial Carcinoma: A type of bladder and urinary tract cancer.
- Kidney Cancer (Renal Cell Carcinoma): Often used in combination with other medications.
- Triple-Negative Breast Cancer: Used in combination with chemotherapy for high-risk early-stage or metastatic cases.
It is also used for cancers that test positive for specific genetic markers, such as Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR), regardless of the tumor’s location.
What to Expect During Administration
Receiving Keytruda is a straightforward process, but it requires regular visits to a clinic or hospital. The medication is delivered through an IV line into a vein, usually in your arm, or through a central port.
Infusion Schedule
Keytruda is typically administered once every three weeks or once every six weeks, depending on the dose prescribed by your oncologist. Each infusion session usually lasts about 30 minutes. Your healthcare provider will determine how many cycles of treatment you need based on how your cancer responds.
Monitoring and Testing
Before each infusion, you will likely undergo blood tests. These tests help your medical team monitor your organ function and ensure that your immune system is not becoming overly active against your own healthy tissues. Consistent monitoring is the best way to catch potential issues early.
Common Side Effects
Because Keytruda activates the immune system, it can cause side effects as the body adjusts. While many people tolerate the treatment well, it is important to be aware of the most common reactions:
- Fatigue: Feeling unusually tired or weak is the most frequently reported side effect.
- Skin Reactions: This may include rashes, itching, or dry skin.
- Digestive Issues: Nausea, constipation, or a decrease in appetite can occur.
- Respiratory Symptoms: Some patients experience a mild cough or shortness of breath.
- Musculoskeletal Pain: Aches in the joints or muscles are common during treatment cycles.
Most of these side effects are manageable with over-the-counter medications or lifestyle adjustments, but you should always report them to your doctor.
Serious Immune-Mediated Side Effects
In some cases, Keytruda can cause the immune system to attack healthy organs and tissues. These are known as immune-mediated adverse reactions. While less common, they can be serious and require immediate medical attention.
Lung and Intestinal Problems
Inflammation of the lungs (pneumonitis) can cause new or worsening cough or chest pain. Similarly, inflammation of the colon (colitis) can lead to diarrhea or severe abdominal pain. If you notice significant changes in your breathing or digestion, contact your healthcare team immediately.
Hormone and Organ Issues
The immune system may affect the thyroid, pituitary, or adrenal glands, leading to hormone imbalances. Symptoms can include extreme tiredness, weight changes, or mood swings. Additionally, inflammation can occur in the liver (hepatitis) or kidneys (nephritis), which is why regular blood work is so vital.
Questions to Ask Your Oncologist
Active communication with your medical team is essential for successful treatment. If you are considering or starting Keytruda, you may want to ask the following questions:
- Is Keytruda being used alone or in combination with other treatments?
- How will we measure if the treatment is working?
- What specific side effects should I watch for based on my medical history?
- Are there any medications or supplements I should avoid during treatment?
- Who should I call if I experience a reaction after clinic hours?
Conclusion
Keytruda has changed the landscape of cancer care by harnessing the power of the human immune system. By understanding how the treatment works and staying vigilant about side effects, patients can play an active role in their recovery journey. Always keep a detailed log of how you feel between infusions and maintain open lines of communication with your oncology team.
For more information on managing health during treatment, you may find our articles on nutrition during recovery and tips for managing treatment-related fatigue helpful. Staying informed is the first step toward effective health management.